Novo Nordisk reports Q1 profits o $3.65 BN as demand for weightloss drug soars

CGTN Europe 2024-05-02

Views 380

Health Reporter for Axios Victoria Knight speaks to CGTN Europe about the policy implications and concerns associated with the booming popularity of the drug.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Q1 Review: PNB Housing Finance Q1 Profit Soars
play
09:40

Q1 Review: PNB Housing Finance Q1 Profit Soars
MongoDB Q1 Revenue Soars 29%
play
00:46

MongoDB Q1 Revenue Soars 29%
Netflix Soars Above Market Expectations for Q1 2018
play
00:50

Netflix Soars Above Market Expectations for Q1 2018
Palantir Technologies stock soars 26% as Q1 tops expectations - $PLTR
play
00:54

Palantir Technologies stock soars 26% as Q1 tops expectations - $PLTR
Japan Post soars in Tokyo trading after $11.5 bn IPO
play
01:06

Japan Post soars in Tokyo trading after $11.5 bn IPO
Airbus net profits soar to 2.7 bn euros on rising orders
play
00:43

Airbus net profits soar to 2.7 bn euros on rising orders
Q1 Review: Emami Reports Strong Q1 Numbers
play
09:40

Q1 Review: Emami Reports Strong Q1 Numbers
Novo Nordisk record profits with weight-loss-drug demand boost
play
03:58

Novo Nordisk record profits with weight-loss-drug demand boost
Three Bottom Lines - One Mindset | Novo Nordisk
play
05:38

Three Bottom Lines - One Mindset | Novo Nordisk
Putting the Cook Back in the Urban Kitchen | Novo Nordisk
play
04:59

Putting the Cook Back in the Urban Kitchen | Novo Nordisk
A Golden Opportunity to Change Diabetes in Johannesburg | Novo Nordisk
play
03:51

A Golden Opportunity to Change Diabetes in Johannesburg | Novo Nordisk
Denmark's Novo Nordisk invests €2.1 billion in France
play
00:10

Denmark's Novo Nordisk invests €2.1 billion in France